Cartesian Therapeutics, Inc.
RNAC
$10.50
-$0.07-0.66%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 176.44% | 3,088.33% | -- | -23.17% | -42.86% |
Total Receivables | -90.15% | 367.71% | -- | -- | -9.29% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -36.70% | 7,996.08% | -- | -- | 42.36% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 138.76% | 2,705.29% | -- | -- | -38.75% |
|
|||||
Total Current Assets | 138.76% | 2,705.29% | -- | -- | -38.75% |
Net Property, Plant & Equipment | 26.81% | 2,022.25% | -- | -- | -15.47% |
Long-term Investments | 0.00% | -- | -- | -- | -- |
Goodwill | 0.00% | -- | -- | -- | -- |
Total Other Intangibles | 0.00% | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 58.82% | 6,576.00% | -- | -- | 2.99% |
Total Assets | 42.61% | 4,789.56% | -- | -- | 83.89% |
|
|||||
Total Accounts Payable | -90.86% | -- | -- | -- | 896.84% |
Total Accrued Expenses | -22.67% | 541.36% | -- | -- | 3.70% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 31.63% | 914.65% | -- | -- | -78.52% |
Total Finance Division Other Current Liabilities | -82.31% | 1,247.26% | -- | -- | 8,043.00% |
Total Other Current Liabilities | -82.31% | 1,247.26% | -- | -- | 8,043.00% |
Total Current Liabilities | -66.32% | 808.92% | -- | -- | 172.00% |
|
|||||
Total Current Liabilities | -66.32% | 808.92% | -- | -- | 172.00% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 26.67% | 1,499.06% | -- | -- | -12.59% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 10.89% | -- | -- | -- | 1,821.01% |
Total Liabilities | -0.64% | 14,572.82% | -- | -- | 517.11% |
|
|||||
Common Stock & APIC | 285.28% | 8,505.84% | -- | -- | -63.70% |
Retained Earnings | -12.60% | -1,915.54% | -- | -- | -55.63% |
Treasury Stock & Other | -0.46% | -- | -- | -- | -0.92% |
Total Common Equity | 98.45% | 102.91% | -- | -224.48% | -569.14% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 98.45% | 102.91% | -- | -224.48% | -569.14% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 95.13% | -87.90% | -- | -224.48% | -248.81% |
|